IL6 and type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA) showed that higher levels of the inflammatory markers, C-reactive protein (CRP) and interleukin (IL)-6, were associated with an increased risk of developing T2D [8].